Prediction of severity of Gaucher's disease by identification of mutations at DNA level

Lancet. 1989 Aug 12;2(8659):349-52. doi: 10.1016/s0140-6736(89)90536-9.

Abstract

The polymerase chain reaction was used to detect four mutations in the DNA of 47 unrelated patients with type I Gaucher's disease (94 Gaucher's disease alleles). Two of the mutations, 1226 and 1448, and a new mutation (XOVR) representing cross-over between the glucocerebrosidase gene and its closely linked pseudogene, were found. There were five genotypes--namely, 1226/1226, 1226/1448, 1226/XOVR, 1226/?, and ?/? (where "?" indicates that none of the four known mutations was present). Severity of the disease was assessed with a scoring index according to age at diagnosis and extent of organ involvement. Mutation 1226 was associated with a mild clinical phenotype, and mutation 1448 with a more severe phenotype. Mutation 1226 is the most common cause of Gaucher's disease in Jewish patients.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Amino Acid Sequence
  • Child
  • Child, Preschool
  • DNA / analysis*
  • Evaluation Studies as Topic
  • Female
  • Gaucher Disease / enzymology
  • Gaucher Disease / genetics*
  • Gene Amplification
  • Genotype
  • Glucosidases / genetics*
  • Glucosylceramidase / genetics*
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutation*
  • Oligonucleotide Probes
  • Severity of Illness Index*

Substances

  • Oligonucleotide Probes
  • DNA
  • Glucosidases
  • Glucosylceramidase